STOCK TITAN

Dimensional Fund Advisors (NYSE: ELAN) discloses 5% passive stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Dimensional Fund Advisors LP filed a Schedule 13G reporting a passive ownership stake in Elanco Animal Health Inc. common stock. As of 12/31/2025, Dimensional is deemed to beneficially own 25,082,545 shares, representing 5.0% of Elanco’s common stock. The firm has sole voting power over 24,595,193 shares and sole dispositive power over 25,082,545 shares.

The shares are actually owned by various funds and accounts advised or sub-advised by Dimensional. Dimensional states that it may be deemed a beneficial owner only for Section 13(d) purposes and expressly disclaims beneficial ownership. The position is certified as being held in the ordinary course of business and not for the purpose of changing or influencing control of Elanco.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Dimensional Fund Advisors LP
Signature:Selwyn Notelovitz
Name/Title:Global Chief Compliance Officer
Date:01/21/2026

FAQ

What stake does Dimensional Fund Advisors LP report in ELAN common stock?

Dimensional Fund Advisors LP reports deemed beneficial ownership of 25,082,545 Elanco Animal Health Inc. common shares, representing 5.0% of the class as of 12/31/2025.

Does Dimensional Fund Advisors LP have voting power over ELAN shares?

Yes. Dimensional reports sole voting power over 24,595,193 Elanco shares and no shared voting power, as of the date of the filing.

Who actually owns the Elanco (ELAN) shares reported by Dimensional Fund Advisors LP?

The shares are owned by various funds and accounts advised or sub-advised by Dimensional Fund Advisors LP or its subsidiaries. Dimensional may have voting and/or investment power but states that all securities are owned by the Funds.

Does Dimensional Fund Advisors LP claim full beneficial ownership of the ELAN shares?

No. Dimensional disclaims beneficial ownership of all reported Elanco shares, stating that it may be deemed a beneficial owner only for Section 13(d) reporting purposes.

Is Dimensional Fund Advisors LP’s position in ELAN intended to influence control of the company?

Dimensional certifies that the Elanco securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of the issuer.

What type of reporting person is Dimensional Fund Advisors LP in this ELAN Schedule 13G?

Dimensional Fund Advisors LP is identified as an investment adviser and is a Delaware limited partnership, filing under the relevant investment adviser category of Schedule 13G.

Elanco Animal Health

NYSE:ELAN

ELAN Rankings

ELAN Latest News

ELAN Latest SEC Filings

ELAN Stock Data

12.08B
491.25M
1.03%
109.82%
5.2%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
INDIANAPOLIS